Company Overview
Blue Heron has been a gene synthesis pioneer and leader since its founding in 1999. We provide the broadest range of synthetic DNA sequences and related services to thousands of researchers across multiple industries.

With our proprietary GeneMaker® technology, we regularly produce perfect DNA sequences from the simplest to the most complex structures, from 60 base pairs to well over 20,000 base pairs in length — including the first synthetic DNA fragment over 50,000 base pairs.

Unlike approaches that rely on adaptations of standard PCR, our GeneMaker platform includes exclusive design software that considers multiple characteristic of each section of the target DNA sequence, and optimally builds each section using multiple, proprietary process technologies. This way, Blue Heron successfully completes projects where our competitors' processes often fail.

Researchers from the leading pharmaceutical and biotechnology companies, as well as emerging synthetic biology, biofuels, and cleantech companies, choose Blue Heron for our unmatched technological capability, quality of customer service, and long record of success and industry leadership.

The demand for perfect DNA sequences is growing geometrically and research projects are becoming much more complex. Blue Heron has the experience and technological know-how to meet this demand today and into the future.

As of August, 2010, Blue Heron became a wholly owned subsidiary of OriGene Technologies, Inc. Combining OriGene’s complete collection of human cDNA clones with Blue Heron’s gene synthesis capacity, we can provide a whole product solution for the molecular biology research community. We are 100% committed to serving our customers with high quality, strict confidentiality standards, and improved business efficiency. Learn More..